The doxycycline inducible system takes advantage of a dominant negative form of TCF1E (dnTCF1E) which when expressed in colon cancer cells, can interfere with endogenous β-catenin-LEF/TCF complexes by competing for occupancy of binding sites throughout the genome (Figure 1A) (31). The gene discussed is HNF4A; the disease is colonic neoplasm.